“Blood Testing Market Report is set to have rapid growth due to constantly increasing geriatric population, advanced technological facilities and introduction of advanced technologies for the POC blood tests at global, regional and national level, influencing the industry trends in each of the sub-segments from 2019 to 2029”, says Visiongain Report

04 September 2019
Pharma

Visiongain has launched a new pharma report Blood Testing Market Forecast 2019-2029: By Test Type (Glucose, Lipid, BUN, A1C, CRP, Vitamin D, ALT, AST, Thyroid Stimulating Hormone), By Region, And Segment Forecasts

With increasing need for identification of infectious agents, cardiovascular diseases, cancer biomarkers, drug abuse, and women’s health issues blood testing market is expected to witness huge growth. A blood test can be used for various ailments like anaemia, infection, leukaemia, hypokalaemia, and kidney abnormalities besides cancer detection. Blood tests have also played great role in lab diagnosis, essential for treatment initiation.

Advancement in technologies have allowed blood testing to be precise, accurate requiring only a drop of blood to assess a biomarker instead of opting for a invasive process. Blood testing also allows for early diagnosis of a disease producing better health outcomes for a patient. Development in blood collecting procedures, analysers, sensors, automated blood testing with seamless transfer of information via digital therapeutics will see the blood testing market boom.

Leading companies featured in the report include Abbott Diagnostics, Bio-Rad Laboratories Inc, Roche Diagnostics, Quest Diagnostics, Biomerica, Inc, Siemens Healthineers (A Subsidiary of Siemens AG), Trinity Biotech PLC, Alere Inc, Beckman Coulter (A Subsidiary Of Danaher Corporation), Becton, Dickinson And Company.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Global Human Microbiome Therapeutics market set to grow to $1.6bn” by 2025 says new Visiongain report

The market for microbiome therapeutics is expected to commence around mid-2020 with the launch of new products relating to dermatology and gastrointestinal disorders.

04 December 2019

Read

“Global Next-Generation Biologics market set to grow to $42bn by 2024” says new Visiongain report

Technological developments in the next-generation biologics market will be the result of clinical development of multiple platforms in the next-generation antibody, antibody fragment and ALP sectors.

04 December 2019

Read

“Global Liquid Biopsy market set to grow to $4.9bn by 2024” says new Visiongain report

The main drivers for the growth include technological advancements such as development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

04 December 2019

Read

“Global nucleic acid isolation and purification market is anticipated to reach USD 8.16 Billion by 2030”, says Visiongain

Nucleic acid separation and purification is one of modern science and technology’s most complex and critical accomplishments.

29 November 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever